en · de · es · pt
assay-notes.peptides4800.com › Topic › Stability, Handling, And Analytical Control — What the Evidence Shows

Stability, Handling, And Analytical Control — What the Evidence Shows

By Editorial Desk · published 2026-01-09 · last reviewed 2026-02-26 · Topic

Research chemical comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.

Updated 2026-02-26. Numbers and descriptions here follow the published literature rather than marketing material.

Stability, Handling, and Analytical Control

Peptide bonds are vulnerable to protease attack, and Selank is no exception. Measured half-life in serum is short, on the order of minutes in several reports, which explains why intranasal administration is the common route described in the literature. Absorption across the nasal mucosa partially bypasses first-pass hepatic metabolism. Quantitative data on human bioavailability remain limited and are difficult to compare across studies.

Lyophilised material kept dry at minus 20 degrees Celsius or colder is the most stable form, and suppliers commonly state a shelf life of two years or more under those conditions. Once dissolved, degradation accelerates through hydrolysis and deamidation, particularly at alkaline pH or elevated temperature. Working solutions are usually divided into single-use aliquots to avoid repeated freeze-thaw cycles. The choice of reconstitution solvent affects both stability and the ionic strength of the final preparation.

Origins and Proposed Mechanisms

Published clinical evidence is limited. Most controlled trials were conducted in Russia, enrolled modest numbers of participants, and appeared in Russian-language journals, which restricts independent verification. Reported outcomes include lower anxiety scores, improved attention and memory measures, and changes in fatigue ratings. Reviews written in English note methodological limitations such as small samples and inconsistent endpoints. Whether the compound produces clinically meaningful benefit relative to established anxiolytics is therefore an open question rather than an established finding.

Selank is a synthetic heptapeptide with the sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro. It was designed at the Institute of Molecular Genetics of the Russian Academy of Sciences as a structural analogue of tuftsin, a naturally occurring tetrapeptide fragment of the immunoglobulin heavy chain. The added Pro-Gly-Pro tail was intended to slow enzymatic degradation and extend biological activity. In Russia it is registered as an anxiolytic nasal preparation, while regulators elsewhere have not approved it for clinical use.

Proposed mechanisms centre on modulation of the GABAergic system, with reports of altered expression of genes related to GABA-A receptor subunits and changed monoamine turnover. Some studies describe inhibition of enkephalinase, the enzyme that degrades endogenous enkephalins, which may prolong opioid peptide signalling. Effects on brain-derived neurotrophic factor and on cytokine expression have also been reported. These findings come largely from animal models and small human studies, and the precise primary target remains unresolved.

Selank at a glance

PropertyValueNotes
Dry storage temperature-20 C or belowSealed, desiccated, protected from light
Solution stabilityHours to days at 2-8 CDepends on buffer and microbial load
Preferred pH rangeNear neutral to slightly acidicAlkaline pH accelerates hydrolysis
Main degradation routesHydrolysis and deamidationNo cysteine or methionine in sequence
Identity confirmationElectrospray mass spectrometryObserved mass compared with 751.9 Da

Storage, Analysis, and Regulatory Status

Dry powder is normally held at -20 degrees Celsius or lower, in a sealed container with desiccant and protection from light. Reconstituted solutions are usually kept at 2 to 8 degrees Celsius for short periods and frozen for longer ones. Proline residues at several positions are generally associated with some resistance to peptidase attack, but chemical stability still declines at neutral to alkaline pH and at elevated temperature. Exact shelf-life figures are product-specific and are not standardised across suppliers.

Identity and purity are usually assessed by reversed-phase high-performance liquid chromatography, with mass spectrometry used to confirm molecular mass and sequence information. Amino acid analysis and peptide mapping may supplement these methods. Certified reference standards are scarce, and many commercial lots are sold as research chemicals without a pharmacopoeial monograph. Regulatory treatment differs by country: Selank is a registered prescription medicine in Russia, while in the European Union and the United States it is not an approved drug and may fall under research-chemical or unapproved-product frameworks.

Related pages on this site

Background and Molecular Identity

Selank is a synthetic heptapeptide with the sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro. Its four N-terminal residues reproduce tuftsin, a tetrapeptide fragment of the immunoglobulin heavy chain, while the C-terminal Pro-Gly-Pro extension is a synthetic addition. The peptide has a molecular mass near 752 daltons and carries a net positive charge at physiological pH because of the arginine and lysine side chains. Published indexes list it under the name Selank and the sequence abbreviation TKPRPGP. Solid-phase peptide synthesis is the standard production route for research quantities.

Development took place at the Institute of Molecular Genetics of the Russian Academy of Sciences, where a series of short peptides were designed in the 1980s and 1990s. Selank was selected from variants of tuftsin that showed resistance to plasma peptidases. Russian regulatory approval covers it as an anxiolytic agent given intranasally. Outside that market the compound is normally handled as a research chemical rather than a medicine, and no widely recognised international pharmacopoeial monograph exists. The name Selank is a coined trade designation rather than a systematic chemical name.

Notes from published material

Has written for The Guardian London Review of Books, Red Pepper (magazine), Novara Media, Radical Philosophy, and has worked with Jews for Justice for Palestinians, Independent Jewish Voices and Faculty for Israeli–Palestinian Peace (FFIPP) engaged in efforts to end the Israeli occupation of Palestinian land and create a just peace between Israel and Palestine. Anthony Seldon (born 2 August 1953); educator, contemporary historian, journalist, broadcaster, academic, author, wrote biographies of British Prime Ministers, John Major, Tony Blair, Gordon Brown, David Cameron, Theresa May and Boris Johnson; was master (headmaster) of Wellington College, one of Britain's co-educational independent boarding schools, and is current Head Master of Epsom College; is author or editor of more than 45 books on contemporary history, politics and education; was co-founder and first director of Centre for Contemporary British History; co-founder of Action for Happiness, is a governor of the Royal Shakespeare Company, and is on board of a number of charities and educational bodies; is honorary historical adviser to 10 Downing Street and member of the First World War Centenary Culture Committee; was knighted in the 2014 Birthday Honours for services to education and modern political history.

=== Rotator cuff disease === A 2022 review and meta-analysis showed improved patient-rated outcomes in patients with partial rotator cuff tears. At 8 weeks post injection, they found PRP to be effective. A 2021 prospective study examined the effectiveness of PRP for partial thickness rotator cuff tears. Patients were given 2 separate PRP injections and followed for 2 years. The study noted: "No adverse events were seen in any patient. Based on global rating scores positive results were seen in 77.9 % of patients at 6 months, 71.6 % at 1 year, and 68.8 % of patients at 2 years". They found PRP most effective in more damaged tendons. A 2021 meta-analysis found that PRP was effective for partial rotator cuff tears but the effects were no longer evident at 1 year. PRP has been shown to be superior to cortisone injections in several studies. This is especially evident in the longer term. A 2019 review found it not to be useful in rotator cuff disease. A 2018 review found that it may be useful. A 2009 review found few randomized controlled trials that adequately evaluated the safety and efficacy of PRP treatments and concluded that PRP was "a promising, but not proven, treatment option for joint, tendon, ligament, and muscle injuries".

Fluids cannot generally be pulled, so a vacuum cannot be created by suction. Suction can spread and dilute a vacuum by letting a higher pressure push fluids into it, but the vacuum has to be created first before suction can occur. The easiest way to create an artificial vacuum is to expand the volume of a container. For example, the diaphragm muscle expands the chest cavity, which causes the volume of the lungs to increase. This expansion reduces the pressure and creates a partial vacuum, which is soon filled by air pushed in by atmospheric pressure. To continue evacuating a chamber indefinitely without requiring infinite growth, a compartment of the vacuum can be repeatedly closed off, exhausted, and expanded again. This is the principle behind positive displacement pumps, like the manual water pump for example. Inside the pump, a mechanism expands a small sealed cavity to create a vacuum. Because of the pressure differential, some fluid from the chamber (or the well, in our example) is pushed into the pump's small cavity. The pump's cavity is then sealed from the chamber, opened to the atmosphere, and squeezed back to a minute size.

In the points where the image is present, the discoloration affects only two or three fibers on the topmost part of the threads of the cloth. In each fiber, the yellow discoloration penetrates only for 200 nm in the external cell layer. A fiber is not necessarily colored for all its length, but, in the parts where it is, it has the property of being colored all around its cylindrical surface. Under the crossing threads of the weave, the image is not present. The discoloration seems caused by a kind of dehydrative oxidation process, which has discolored and chemically altered the surfaces of certain surface fibrils. The image of the Shroud is an areal density image, in the sense that the levels of darkness are not given by variations of the color, which instead is approximately constant all over the image, but by a variation of the number of yellowed fibers per unit area. Therefore, it can be considered a halftone image. Furthermore, there is no difference in terms of distribution of fiber coloration and maximum densities between the front and the rear of the image. While the blood images could have come from a contact mechanism, the body image could not. The mapping between body-only image densities and expected cloth–body distances is not consistent with the image having been formed by direct contact with a body, as it is present even when it does not seem possible for the cloth to be in contact with the body.

== Composition == Most hotspot volcanoes are basaltic (e.g., Hawaii, Tahiti). As a result, they are less explosive than subduction zone volcanoes, in which water is trapped under the overriding plate. Where hotspots occur in continental regions, basaltic magma rises through the continental crust, which melts to form rhyolites which can form violent eruptions. For example, the Yellowstone Caldera was formed by some of the most powerful volcanic explosions in geologic history. However, when the rhyolite is completely ejected, it may be followed by eruptions of basaltic magma rising through the same lithospheric fissures (cracks in the lithosphere). An example of this activity is the Ilgachuz Range in British Columbia, which was created by an early complex series of trachyte and rhyolite eruptions, and late extrusion of a sequence of basaltic lava flows. The hotspot hypothesis is now closely linked to the mantle plume hypothesis. The detailed compositional studies now possible on hotspot basalts have allowed linkage of samples over the wider areas often implicate in the later hypothesis, and its seismic imaging developments.

Sources: en.wikipedia.org

Further detail

Cabinets of Lower Saxony Since 1948, politics in the state have been dominated by the centre-right Christian Democratic Union (CDU) and the centre-left Social Democratic Party (SPD). Lower Saxony was one of the origins of the German environmentalist movement in reaction to the state government's support for underground nuclear waste disposal. This led to the formation of the German Green Party in 1980. Germany's multi-party system generally requires coalitions to be made because parties usually do not have outright majorities. The Minister-President heads the state government, acting as a head of state (even if the federated states have the status of a state do not establish the office of a head of state but merge the functions with the head of the executive branch) as well as the government leader. They are elected by the Landtag of Lower Saxony. The former Minister-President, Christian Wulff, led a coalition of his CDU with the Free Democratic Party between 2003 and 2010. In the 2008 election, the ruling CDU held on to its position as the leading party in the state, despite losing votes and seats. The CDU's coalition with the Free Democratic Party retained its majority although it was cut from 29 to 10. The election also saw the entry into the state parliament for the first time of the leftist The Left party. On 1 July 2010 David McAllister was elected Minister-President. After the state election on 20 January 2013, Stephan Weil of the Social Democrats was elected as the new Minister-President. He governed in coalition with the Greens.

=== Marketed === Daridorexant (nemorexant; Quviviq) – dual OX1 and OX2 antagonist – approved for insomnia in January 2022, formerly under development for sleep apnea – half-life 8 hours Fazamorexant (Mengping) – dual OX1 and OX2 antagonist – approved for insomnia in China in May 2026 – half-life 2–4 hours Lemborexant (Dayvigo) – dual OX1 and OX2 antagonist – approved for insomnia in December 2019 and released June 1 2020, under development for circadian rhythm sleep disorders, chronic obstructive pulmonary disease, and sleep apnea – half-life 17–55 hours Suvorexant (Belsomra) – dual OX1 and OX2 antagonist – approved for insomnia in August 2014, under development for delirium – half-life 12 hours Vornorexant (Vorzzz) – dual OX1 and OX2 antagonist – approved for insomnia in Japan in August 2025 – half-life 1.5–3 hours

However, salmon RIA appears to allow interspecies assessment of plasma lep levels. This only confirms that more comprehensive studies are needed for conclusive data interpretation. Studies on rainbow trout also implicated Lep as an anorectic hormone as in mammals. Injection of rainbow trout with recombinant trout leptin (rt-leptin) resulted in a significantly reduced appetite over two days that coincided with a decrease in hypothalamic mRNA expression of neuropeptide Y (npy) and increase of pomc mRNAs, respectively. Whether these observations are due to species-specific differences in long-term leptin regulation of appetite or growth is not known, however, consensus data indicate that the effects of Lep on appetite regulation may be short-term in teleosts.

== Physiological distribution == Lipases are involved in diverse biological processes which range from routine metabolism of dietary triglycerides to cell signaling and inflammation. Thus, some lipase activities are confined to specific compartments within cells while others work in extracellular spaces.

Sources: en.wikipedia.org

Background from the literature

=== High-altitude illnesses === Dexamethasone is used in the treatment of high-altitude cerebral edema (HACE), as well as high-altitude pulmonary edema (HAPE). It is commonly carried on mountain-climbing expeditions to help climbers deal with complications of altitude sickness.

Bleecker Banks* (1850s), mayor of Albany, New York; member of New York State Assembly and New York State Senate Galen A. Carter (1850), member of Connecticut Senate Stewart L. Woodford (1854), lieutenant governor of New York and U.S. minister to Spain Jacob Augustus Geissenhainer (1858), U.S. congressman from New Jersey George Lockhart Rives (1868), U.S. assistant secretary of state and chairman of the Columbia trustees Hamilton Fish II (1869), speaker of the New York State Assembly and U.S. congressman Thomas C. E. Ecclesine (1870), member of the New York State Assembly and the New York State Senate Seth Low (1870), mayor of New York City and president of Columbia University Oscar Solomon Straus (1871), first Jewish U.S. cabinet secretary, U.S. secretary of commerce and labor under Theodore Roosevelt, and U.S. ambassador to the Ottoman Empire, first president of the American Jewish Historical Society Robert Anderson Van Wyck (1871), first mayor of New York City to preside over all five boroughs Robert Ray Hamilton (1872), member of New York State Assembly, great-grandson of Alexander Hamilton P. Henry Dugro (1876), U.S. congressman from New York Benjamin Barker Odell Jr.* (1877), governor of New York; U.S. congressman from New York Thomas G. Patten (1879), U.S. congressman from New York Thomas F. Magner (1882), U.S. congressman from New York Thomas Ewing III (1883), 33rd commissioner of the United States Patent and Trademark Office Herbert L. Satterlee (1883), assistant secretary of the Navy 1908–1909, son-in-law of J. P.

=== 2000–2005 === In 2000, the company acquired Hitech Pathology (Victoria) that merged with Melbourne Pathology. In 2001, Sonic Healthcare acquired Castlereagh Imaging (New South Wales), Castlereagh Imaging Hong Kong (HK), Hunter Imaging Group (New South Wales), Illawarra Radiology Group (New South Wales), Canterbury Medical Imaging (New Zealand), Palmerston North X-Ray (New Zealand), (through Sullivan Nicolaides Pathology) Consultant Pathologists in Townsville (Queensland) and Cairns Pathology Laboratory (Queensland), Queensland X-Ray Group, Illawarra Medical Laboratories (New South Wales), Clinipath Pathology (Western Australia), La Trobe Pathology (Victoria) and Bunbury Pathology (Western Australia) from Foundation Healthcare, and SKG Radiology (Western Australia's largest private diagnostic imaging practice). In 2002, the company acquired The Doctors Laboratory, Britain's largest private pathology practice. Through Sullivan Nicolaides the company acquired the practice of Tom Lynch in Rockhampton (Queensland). Through SKG Radiology, the company acquired Fremantle Radiology (Western Australia). Sonic Healthcare acquired Richard Haskell's NSW Central Coast Pathology practice in 2003, along with the Southside Diagnostic Services Group in Brisbane. In the UK, the company acquired Omnilabs Pathology, merging it into The Doctors Laboratory.

Sources: en.wikipedia.org

Frequently asked questions

How should the powder be stored?

Dry powder is best kept sealed, protected from light, and held at minus 20 degrees Celsius or below. Desiccant packaging helps limit moisture uptake because the material is hygroscopic. A sealed vial should be allowed to equilibrate to room temperature before opening to reduce condensation.

What limits shelf life in solution?

Hydrolysis of peptide bonds and deamidation of arginine and proline residues are the main degradation routes. Alkaline pH and higher temperatures accelerate both processes. Buffered, near-neutral solutions stored cold generally degrade more slowly than unbuffered ones.

Which purity test is most informative?

Reverse-phase chromatography gives the clearest single view of related impurities and truncated sequences. Mass spectrometry then confirms that the main peak carries the expected mass. Neither test detects enantiomeric impurities, which require a separate chiral assay.

What is Selank made of?

It is a seven-amino-acid peptide, Thr-Lys-Pro-Arg-Pro-Gly-Pro, produced by chemical synthesis rather than extracted from biological tissue. Its design is based on tuftsin, a natural immunomodulatory tetrapeptide. The C-terminal Pro-Gly-Pro segment is a common stabilising motif in short regulatory peptides.

Network